International Patent: FUSION PROTEIN PEGTEPSKINASE WITH TARGETED THROMBOLYTIC EFFECT, PREPARATION METHOD THEREFOR, AND USE THEREOF

GENEVA, July 31 -- ZONHON BIOPHARMA INSTITUTE, INC. filed a patent application (CN2026/073851) for “FUSION PROTEIN PEGTEPSKINASE WITH TARGETED THROMBOLYTIC EFFECT, PREPARATION METHOD THEREFOR, AND USE THEREOF”. With publication no. WO/2026/158337, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 9/64

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....